BIOMARKERS TO DETECT CENTRAL DOPAMINE DEFICIENCY AND DISTINGUISH PARKINSON DISEASE FROM MULTIPLE SYSTEM ATROPHY

OBJECTIVE: Biomarkers are increasingly important to diagnose and test treatments of neurodegenerative diseases such as Parkinson disease (PD). This study compared neuroimaging, neurochemical, and olfactory potential biomarkers to detect central dopamine (DA) deficiency and distinguish PD from multip...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Goldstein, David S., Holmes, Courtney, Bentho, Oladi, Sato, Takuya, Moak, Jeffrey, Sharabi, Yehonatan, Imrich, Richard, Conant, Shielah, Eldadah, Basil A.
Формат: Artigo
Язык:Inglês
Опубликовано: 2008
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2650101/
https://ncbi.nlm.nih.gov/pubmed/18325818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.parkreldis.2008.01.010
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы